Fatigue Treatment Using Provigil
NCT00220506 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2006-02-17
Summary
To determine whether therapy with Modafinal(Provigil) is safe and effective in fatigue in MS Patients
Conditions
- All Multiple Sclerosis Patients
Interventions
- DRUG
-
Provigil
Sponsors & Collaborators
-
Sheba Medical Center
lead OTHER_GOV
Principal Investigators
-
Mark Dolev, MD · Sheba Medical Center
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-09-30
- Completion
- 2006-12-31
Countries
- Israel
Study Locations
More Related Trials
-
Role of Microglial Activation and Norepinephrine Transporter Abnormalities in Pathogenesis of MS-related Fatigue
NCT04144257 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Modafinil in Multiple Sclerosis
NCT00142402 ·Status: COMPLETED ·Phase: NA
-
Multimodal Exploration of Patients With Multiple Sclerosis for an Early Detection of Subtle Progression
NCT05941975 ·Status: RECRUITING ·Phase: NA
-
Efficacy of L-carnitine Versus Placebo in the Treatment of Fatigue in Multiple Sclerosis
NCT01149525 ·Status: COMPLETED ·Phase: PHASE3
-
Cognitive Behavioral Therapy, Modafinil, or Both for Multiple Sclerosis Fatigue
NCT03621761 ·Status: COMPLETED ·Phase: PHASE4
-
Non-interventional Study of Ocrelizumab in Participants With Relapsing or Primary Progressive Multiple Sclerosis
NCT03593590 ·Status: COMPLETED
-
Effects of Gilenya (Fingolimod) on Thalamus Pathology and Cognitive Impairment in Patients With Relapsing Forms of Multiple Sclerosis
NCT02021162 ·Status: COMPLETED
-
A Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
NCT04035005 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Dose-finding Study for SAR442168 in Relapsing Multiple Sclerosis
NCT03889639 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Suvorexant in Patients With Multiple Sclerosis Fatigue and Insomnia
NCT03110315 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Masitinib in the Treatment of Progressive Multiple Sclerosis
NCT01433497 ·Status: COMPLETED ·Phase: PHASE3
-
Methylphenidate as Treatment Option of Fatigue in Multiple Sclerosis
NCT01879202 ·Status: UNKNOWN ·Phase: PHASE2
-
Ocrelizumab Effects on Physiological and Cognitive Changes in Multiple Sclerosis
NCT03025269 ·Status: COMPLETED
-
Impact of Armodafinil on Neurocognition and Cognitive Fatigue in Multiple Sclerosis (MS)
NCT00981084 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Testing Mitochondria Activity and Blood Lipid Content of Multiple Sclerosis Patients
NCT01918501 ·Status: UNKNOWN ·Phase: NA
-
Effectiveness of a One-year Group Program for Fatigue Management in Minimally Impaired People With Multiple Sclerosis
NCT07028879 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Open-Label Placebos to Treat Fatigue in Multiple Sclerosis
NCT04002102 ·Status: COMPLETED ·Phase: NA
-
A Study to Provide Complementary Efficacy, Safety and Patient Reported Outcomes Data in Participants With Active Relapsing Forms of Multiple Sclerosis (MS) in a Pragmatic Setting
NCT03589105 ·Status: COMPLETED ·Phase: PHASE4
-
Ketamine for MS Fatigue
NCT06064162 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Evaluation of Natalizumab for thE Relief of MS Associated FatiGue
NCT00464074 ·Status: COMPLETED
-
A Study to Evaluate Ocrelizumab Treatment in Participants With Progressive Multiple Sclerosis
NCT03523858 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Exploring Diroximel Fumarate Real-world Experience in Canada and Israel
NCT04948606 ·Status: TERMINATED
-
Investigation of the Effect of the MIND Diet on Disease Symptoms in Patients With MS
NCT07057999 ·Status: COMPLETED ·Phase: NA
-
Effect of Ocrelizumab on Neuroinflammation in Multiple Sclerosis as Measured by 11C-PBR28 MR-PET Imaging of Microglia Activation
NCT04230174 ·Status: COMPLETED ·Phase: PHASE4
-
A Study for Patients With Relapsing Remitting Multiple Sclerosis
NCT00869986 ·Status: COMPLETED ·Phase: PHASE2/PHASE3